overactive bladder (OAB) non-obstructive urinary retention (NOR) sacral neuromodulation (SNM) overactieve blaas niet-obstructieve urine retentie sacrale neuromodulatie
Conditions
Interventions
After inclusion and informed consent, patients will fill out a baseline voiding diary throughout seven days. The 28 day test stimulation period starts on the day of the first tined lead procedure. On
Sponsors
Department of Urology,
dr. van Koeveringe, urologist
Maastricht Universitair Medisch Centrum
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: Patients should have been diagnosed with overactive bladder syndrome or non-obstructive urinary retention and should be put on the waiting list for scheduling treatment with sacral neuromodulation.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: a) patients receiving neurological or psychiatric medication without being diagnosed with a neurological or psychiatric disease; b) patients who have been treated by means of bladder wall botuline toxine injections in the past twelve months; c) patients with evident subsequent complains of bladder pain syndrome or other pelvic pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The transition point between no effect and time of onset is determined by assessing when certain complaints parameters are reduced by 50% compared to baseline per 24 hours. Vice versa (50% increase) for offset of effect. Onset and offset of effect will be assessed in days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Contacts
Public ContactJ. Drossaerts
Maastricht Universitair Medisch Centrum Afdeling Urologie | P. Debyelaan 25 | postbus 5800
Outcome results
None listed